<?xml version="1.0" encoding="UTF-8"?>
<p id="Par2">Parkinson disease (PD) is one of the most common neurodegenerative disorders affects elderly populations. Over 10 million people are affected by PD world-wide
 <sup>
  <xref ref-type="bibr" rid="CR1">1</xref>
 </sup>. The major hallmark of PD is an irreversible loss of dopaminergic neurons at substantia nigra region of the brain. Loss of dopaminergic neurons exhibit cardinal symptoms such as tremor, rigidity, and bradykinesia. Diagnosis of PD relies on medical history and radiological imaging
 <sup>
  <xref ref-type="bibr" rid="CR2">2</xref>,
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup>. Currently, there is no molecular markers are available to detect PD. Several epidemiological studies suggest multiple risk factors for PD, which includes aging, genetic mutation, and environmental exposure of metals and pesticides
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>,
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup>. The genetic association of PD is well established, which reports PARK loci in most of the GWAS studies
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>
 </sup>. In contrast, the mechanism of metals and pesticide exposures contributing PD is largely unknown.
</p>
